You are here: Industry Insights > Genezen

News List

Genezen Appoints Laura Jacanin as Senior Director of Business Development contractpharma
January 26, 2022
Jacanin brings over 20 years’ experience in the life science sector and has extensive cell and gene therapies and biologics..
Treadwell Therapeutics and CDMO Genezen Enter Cell Therapy Partnership contractpharma
January 20, 2022
Will advance Treadwell’s T cell receptor-based cell therapy pipeline.
Genezen Opens New Process Development and Analytical Lab contractpharma
December 14, 2021
Marks a milestone for the company in launching additional early-stage capabilities needed to drive the cell and gene therapy industry forward.
Genezen Breaks Ground on cGMP Lentiviral Vector Production Facility contractpharma
June 28, 2021
First phase will see the construction of a 25,000 square feet site including a process development lab expansion.
Genezen begins construction of cGMP lentiviral production facility cphi-online
June 28, 2021
Genezen has made a start on turning its new multiphase master plan for a 75,000-sq. ft cGMP-compliant lentiviral vector production facility into reality.
Genezen Laboratories Receives Growth Equity Investment contractpharma
January 06, 2021
Genezen Laboratories Inc. has received a majority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the healthcare sector.